In silico clinical trials: concepts and early adoptionsFrancesco Pappalardo, Marco Viceconti, Giulia Russo et al.|Briefings in Bioinformatics|2018Cited by 267
Population Pharmacokinetic Modeling and Optimal Sampling Strategy for Bayesian Estimation of Amikacin Exposure in Critically Ill Septic PatientsIsabelle Delattre, Pierre Wallemacq, Flora T. Musuamba et al.|Therapeutic Drug Monitoring|2010Cited by 57
Population pharmacokinetics of four β-lactams in critically ill septic patients comedicated with amikacinIsabelle Delattre, Pierre Wallemacq, Philippe Jacqmin et al.|Clinical Biochemistry|2012Cited by 34
Empirical models for dosage optimization of four β-lactams in critically ill septic patients based on therapeutic drug monitoring of amikacinIsabelle Delattre, Pierre Wallemacq, Fabio Silvio Taccone et al.|Clinical Biochemistry|2009Cited by 24
Population Pharmacokinetics of Hydroxychloroquine in COVID-19 Patients: Implications for Dose OptimizationPauline Thémans, Flora T. Musuamba, Leïla Belkhir et al.|European Journal of Drug Metabolism and Pharmacokinetics|2020Cited by 12